{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T15:18:03Z","timestamp":1773847083165,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14403-6","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T06:49:34Z","timestamp":1751352574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sex-disaggregated analysis of breast cancer prevalence in Sierra Leone"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0226-841X","authenticated-orcid":false,"given":"Augustus","family":"Osborne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"3","key":"14403_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"14403_CR2","doi-asserted-by":"publisher","first-page":"e885","DOI":"10.1016\/S2214-109X(18)30257-2","volume":"6","author":"JK Birnbaum","year":"2018","unstructured":"Birnbaum JK, Duggan C, Anderson BO, Etzioni R. Early detection and treatment strategies for breast cancer in low-income and upper middle-income countries: a modelling study. Lancet Global Health. 2018;6(8):e885\u201393.","journal-title":"Lancet Global Health"},{"key":"14403_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12957-018-1345-2","volume":"16","author":"SO Azubuike","year":"2018","unstructured":"Azubuike SO, Muirhead C, Hayes L, McNally R. Rising global burden of breast cancer: the case of sub-Saharan Africa (with emphasis on Nigeria) and implications for regional development: a review. World J Surg Oncol. 2018;16:1\u20133.","journal-title":"World J Surg Oncol"},{"issue":"12","key":"14403_CR4","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1177\/15353702211006047","volume":"246","author":"CA Anyigba","year":"2021","unstructured":"Anyigba CA, Awandare GA, Paemka L. Breast cancer in sub-Saharan africa: the current state and uncertain future. Experimental Biology Med. 2021;246(12):1377\u201387.","journal-title":"Experimental Biology Med"},{"issue":"1","key":"14403_CR5","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1186\/s12889-022-14104-w","volume":"22","author":"J Zembe","year":"2022","unstructured":"Zembe J, Senkubuge F, Botha T, Achoki T. Population health trends analysis and burden of disease profile observed in Sierra Leone from 1990 to 2017. BMC Public Health. 2022;22(1):1801.","journal-title":"BMC Public Health"},{"key":"14403_CR6","unstructured":"Sankoh O, Sevalie S, Mayei A, Smart F, N\u2019jai AU, Kenneh S, NAVIGATING CHALLENGES IN HEALTH SYSTEMS STRENGTHENING: A CLOSER LOOK AT SIERRA LEONE\u2019S JOURNEY TOWARD HEALTHCARE RESILIENCE. Sierra Leone J Biomedical Res. 2024;15(1)."},{"key":"14403_CR7","unstructured":"Neville A. Experiences of Women in Sierra Leone Relating to Accessing Breast Cancer Treatment (Doctoral dissertation, Walden University).2022."},{"key":"14403_CR8","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1245\/s10434-017-5977-1","volume":"24","author":"LA Newman","year":"2017","unstructured":"Newman LA. Breast cancer disparities: socioeconomic factors versus biology. Ann Surg Oncol. 2017;24:2869\u201375.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"14403_CR9","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/cncr.34008","volume":"128","author":"M Kaur","year":"2022","unstructured":"Kaur M, Joshu CE, Visvanathan K, Connor AE. Trends in breast cancer incidence rates by race\/ethnicity: patterns by stage, socioeconomic position, and geography in the united states, 1999-2017. Cancer. 2022;128(5):1015\u201323.","journal-title":"Cancer"},{"issue":"1","key":"14403_CR10","doi-asserted-by":"publisher","first-page":"9347","DOI":"10.1038\/s41598-025-93883-9","volume":"15","author":"Y Cai","year":"2025","unstructured":"Cai Y, Dai F, Ye Y, Qian J. The global burden of breast cancer among women of reproductive age: a comprehensive analysis. Sci Rep. 2025;15(1):9347.","journal-title":"Sci Rep"},{"issue":"3","key":"14403_CR11","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1016\/S1470-2045(13)70547-3","volume":"15","author":"K Chalkidou","year":"2014","unstructured":"Chalkidou K, Marquez P, Dhillon PK, Teerawattananon Y, Anothaisintawee T, Gadelha CA, Sullivan R. Evidence-informed frameworks for cost-effective cancer care and prevention in low, middle, and high-income countries. Lancet Oncol. 2014;15(3):e119\u201331.","journal-title":"Lancet Oncol"},{"issue":"10","key":"14403_CR12","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/S1470-2045(11)70141-3","volume":"12","author":"R Sullivan","year":"2011","unstructured":"Sullivan R, Peppercorn J, Sikora K, Zalcberg J, Meropol NJ, Amir E, Khayat D, Boyle P, Autier P, Tannock IF, Fojo T. Delivering affordable cancer care in high-income countries. Lancet Oncol. 2011;12(10):933\u201380.","journal-title":"Lancet Oncol"},{"key":"14403_CR13","unstructured":"Joko Walburga Epse Fru YA. Burden and trends in cancers of the breast in sub-Saharan Africa (Doctoral dissertation, University of Oxford).2021."},{"issue":"11","key":"14403_CR14","doi-asserted-by":"publisher","first-page":"e2443198","DOI":"10.1001\/jamanetworkopen.2024.43198","volume":"7","author":"HM Bizuayehu","year":"2024","unstructured":"Bizuayehu HM, Ahmed KY, Kibret GD, Dadi AF, Belachew SA, Bagade T, Tegegne TK, Venchiarutti RL, Kibret KT, Hailegebireal AH, Assefa Y. Global disparities of cancer and its projected burden in 2050. JAMA Netw Open. 2024;7(11):e2443198.","journal-title":"JAMA Netw Open"},{"key":"14403_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13031-019-0248-3","volume":"14","author":"S Witter","year":"2020","unstructured":"Witter S, Zou G, Diaconu K, Senesi RG, Idriss A, Walley J, Wurie HR. Opportunities and challenges for delivering non-communicable disease management and services in fragile and post-conflict settings: perceptions of policymakers and health providers in Sierra Leone. Confl Health. 2020;14:1\u20134.","journal-title":"Confl Health"},{"key":"14403_CR16","unstructured":"World Health Organization. International Classification of Diseases-ICD.2009."},{"issue":"8","key":"14403_CR17","doi-asserted-by":"publisher","first-page":"e1027","DOI":"10.1016\/S2214-109X(20)30215-1","volume":"8","author":"E Heer","year":"2020","unstructured":"Heer E, Harper A, Escandor N, Sung H, McCormack V, Fidler-Benaoudia MM. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. Lancet Global Health. 2020;8(8):e1027\u201337.","journal-title":"Lancet Global Health"},{"key":"14403_CR18","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s10549-020-05561-1","volume":"180","author":"Z Chen","year":"2020","unstructured":"Chen Z, Xu L, Shi W, Zeng F, Zhuo R, Hao X, Fan P. Trends of female and male breast cancer incidence at the global, regional, and National levels, 1990\u20132017. Breast Cancer Res Treat. 2020;180:481\u201390.","journal-title":"Breast Cancer Res Treat"},{"key":"14403_CR19","unstructured":"Ayeni OA. Multimorbidity and breast cancer in Sub-Saharan Africa: profile and impact on stage at diagnosis and breast cancer treatment decisions (Doctoral dissertation, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg). 2021."},{"issue":"9","key":"14403_CR20","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1634\/theoncologist.2013-0243","volume":"18","author":"SB Wheeler","year":"2013","unstructured":"Wheeler SB, Reeder-Hayes KE, Carey LA. Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research. Oncologist. 2013;18(9):986\u201393.","journal-title":"Oncologist"},{"issue":"2","key":"14403_CR21","doi-asserted-by":"publisher","first-page":"e0171024","DOI":"10.1371\/journal.pone.0171024","volume":"12","author":"CP Akuoko","year":"2017","unstructured":"Akuoko CP, Armah E, Sarpong T, Quansah DY, Amankwaa I, Boateng D. Barriers to early presentation and diagnosis of breast cancer among African women living in sub-Saharan Africa. PLoS ONE. 2017;12(2):e0171024.","journal-title":"PLoS ONE"},{"key":"14403_CR22","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1200\/GO.21.00282","volume":"7","author":"V Vanderpuye","year":"2021","unstructured":"Vanderpuye V, Dadzie MA, Huo D, Olopade OI. Assessment of breast cancer management in Sub-Saharan Africa. JCO Global Oncol. 2021;7:1593\u2013601.","journal-title":"JCO Global Oncol"},{"issue":"3","key":"14403_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"key":"14403_CR24","unstructured":"AL Farsi S. The Epidemiology of Breast Cancer in Oman (Doctoral dissertation, University of Otago). 2014."},{"key":"14403_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.breast.2022.09.009","volume":"66","author":"H\u00c7 Y\u0131ld\u0131r\u0131m","year":"2022","unstructured":"Y\u0131ld\u0131r\u0131m H\u00c7, Mutlu E, Chalabiyev E, \u00d6zen M, Keskink\u0131l\u0131\u00e7 M, \u00d6n S, \u00c7elebi A, Dursun B, Acar \u00d6, Kahraman S, Aykan MB. Clinical outcomes of cyclin-dependent kinase 4\u20136 (CDK 4\u20136) inhibitors in patients with male breast cancer: a multicenter study. Breast. 2022;66:85\u20138.","journal-title":"Breast"},{"issue":"3","key":"14403_CR26","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s10549-023-07145-1","volume":"203","author":"JL Blum","year":"2024","unstructured":"Blum JL, DiCristo C, Gordon D, Karuturi MS, Oubre D, Jepsen E, Cuevas J, Lakhanpal S, Montelongo MZ, Zhang Z, Cappelleri JC. Outcomes of male patients with HR+\/HER2\u2013advanced breast cancer receiving Palbociclib in the real-world POLARIS study. Breast Cancer Res Treat. 2024;203(3):463\u201375.","journal-title":"Breast Cancer Res Treat"},{"key":"14403_CR27","doi-asserted-by":"crossref","unstructured":"Fentiman I. Advanced male breast cancer. InMale breast cancer.2025 Apr 22 (pp. 189\u2013200). Cham: Springer Nature Switzerland.","DOI":"10.1007\/978-3-031-89929-4_11"},{"issue":"3","key":"14403_CR28","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s10147-023-02460-5","volume":"29","author":"H\u00c7 Y\u0131ld\u0131r\u0131m","year":"2024","unstructured":"Y\u0131ld\u0131r\u0131m H\u00c7, Kutlu Y, Mutlu E, Aykan MB, Korkmaz M, Yal\u00e7\u0131n S, \u015eakalar T, Celayir \u00d6M, Kay\u0131k\u00e7\u0131o\u011flu E, Aslan F, Haf\u0131zo\u011flu E. The efficacy of Palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study. Int J Clin Oncol. 2024;29(3):258\u201365.","journal-title":"Int J Clin Oncol"},{"issue":"11","key":"14403_CR29","doi-asserted-by":"publisher","first-page":"e70054","DOI":"10.1002\/cnr2.70054","volume":"7","author":"L Sch\u00f6nfeld","year":"2024","unstructured":"Sch\u00f6nfeld L, M\u00f6hring C, Strobel R, Kaatsch HL, Waldeck S, Wagner U. Abemaciclib and letrozole in metastatic male breast Cancer. Cancer Rep. 2024;7(11):e70054.","journal-title":"Cancer Rep"},{"key":"14403_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.breast.2020.08.010","volume":"54","author":"S Konduri","year":"2020","unstructured":"Konduri S, Singh M, Bobustuc G, Rovin R, Kassam A. Epidemiology of male breast cancer. Breast. 2020;54:8\u201314.","journal-title":"Breast"},{"issue":"1","key":"14403_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00428-021-03190-7","volume":"480","author":"S Fox","year":"2022","unstructured":"Fox S, Speirs V, Shaaban AM. Male breast cancer: an update. Virchows Arch. 2022;480(1):85\u201393.","journal-title":"Virchows Arch"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14403-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14403-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14403-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T06:49:37Z","timestamp":1751352577000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14403-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14403"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14403-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not seek ethical clearance since the WHO HEAT software, and the dataset are freely available in the public domain.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1022"}}